Actively Recruiting
Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2024-08-05
150
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is the prospective, observational cohort study (Radiogenomics-Liver), which aims to explore the relationship between the imaging information of liver cancer patients, tumor microenvironment and the prognosis of liver cancer patients.
CONDITIONS
Official Title
Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated for liver cancer in Wuhan Union Hospital from August 2024 to August 2027
- Aged > 18 years old
- At least one CT scan or MRI scan before treatment
- Tissue biopsy pathological examination confirmed the diagnosis of liver cancer tumors
You will not qualify if you...
- Poor image quality
- Incomplete clinical data or loss of follow-up
- Presence of another primary malignancy other than liver cancer
- Unclear pathological diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
L
Lian Yang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here